Marco Bandini
Vita-Salute San Raffaele University
DissectionInternal medicineRadiologyUrologySurgeryOncologyCatalysisStage (cooking)ChemistryCystectomyChemotherapyProstatectomyPembrolizumabProstate cancerBladder cancerLymph nodeIn patientProportional hazards modelMedicine
Publications 312
#1Sanjay KulkarniH-Index: 10
#2Pankaj JoshiH-Index: 9
Last. Tony Mundy (UCLH: University College London Hospitals NHS Foundation Trust)H-Index: 1
view all 10 authors...
#1Lorenzo Lombardi (UNIBO: University of Bologna)H-Index: 3
#2Raffaello MazzaroH-Index: 20
Last. Marco Bandini (UNIBO: University of Bologna)H-Index: 26
view all 7 authors...
A new type of ligand-free Ni-nanoparticles supported on rGO (size distribution average d = 9 ± 3 nm) is prepared and fully characterized via morphological (Fe-SEM), structural (P-XRD, HR-TEM) and spectroscopic (ICP-EOS, XPS) analysis tools. The metal composite was effectively employed in the unprecedented heterogeneously Ni-assisted cross-coupling reaction of aryl/vinyl iodides and thiocarboxylates. A range of sulphur-containing aryl as well as vinyl derivatives (15 examples) was achieved in hig...
#1Andrea Necchi (UniSR: Vita-Salute San Raffaele University)H-Index: 12
#2Daniele Raggi (University of Milan)H-Index: 21
Last. Yair Lotan (UTSW: University of Texas Southwestern Medical Center)H-Index: 110
view all 11 authors...
Abstract null null Purpose null Clinical high-grade (HG) T1 non-muscle invasive bladder cancer (NMIBC) represents a significant risk to patients, but these patients are not typically offered neoadjuvant therapies, including immune therapy. In this study, we determine whether patients with HG clinical T1 or T2 bladder urothelial carcinoma (UC) have profiles that predict the potential effectiveness of immune-checkpoint inhibitors (ICI). null null null Materials and Methods null Data from transuret...
#1Marco Bandini (UniSR: Vita-Salute San Raffaele University)H-Index: 26
#2Giuseppina CalaresoH-Index: 16
Last. Andrea NecchiH-Index: 41
view all 18 authors...
Abstract Interim data from the PURE-01 study, using pembrolizumab before radical cystectomy in muscle-invasive bladder cancer (MIBC), suggested that multiparametric magnetic resonance imaging (mpMRI) was able to predict the pathologic response. Owing to the availability of novel effective therapies in MIBC, the possibility to assess tumor response easily has become exceedingly important. The primary objective of the present study was to evaluate the association between individual and combined MR...
#7Benjamin Ayres (St George’s University Hospitals NHS Foundation Trust)H-Index: 5
BACKGROUND Data on the impact of human papillomavirus (HPV) infection status and outcomes for perioperative treatments for patients with lymph node-involved penile squamous-cell carcinoma (PSCC) are lacking. OBJECTIVE To analyze the benefit from perioperative radiotherapy (RT) for PSCC according to HPV infection status. DESIGN, SETTING, AND PARTICIPANTS In an international multicenter database of 1254 patients with PSCC who received inguinal lymph node dissection (ILND), 507 had suitable clinica...
#2Aaron Dahmen (USF: University of South Florida)H-Index: 3
Last. Philippe E. SpiessH-Index: 38
view all 21 authors...
OBJECTIVES To identify incidence and risk factors for upstaging from cN1 to pN2/N3 at inguinal lymphadenectomy (ILND) for penile cancer (pSCC). Our secondary objective is to assess survival outcomes and associations for cN1 patients undergoing ILND. SUBJECTS/PATIENTS AND METHODS Patients with pT≥1cN1cM0 pSCC who underwent bilateral ILND and had complete data were identified in a multi-institutional international cohort from 8 referral centers in 7 countries diagnosed from 1980 to 2017. Upstaging...
#1Laura MarandinoH-Index: 10
#2Antonella CapozzaH-Index: 2
Last. Andrea NecchiH-Index: 41
view all 20 authors...
Abstract Background Data regarding the incidence and prognostic impact of immune-related imaging changes, assessed by 18[F] fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan, in patients receiving immune-checkpoint inhibitors (ICIs) are lacking. We relied on the population of patients enrolled in the PURE-01 study to evaluate such changes. Objective To evaluate the role of PET/CT to visualize the immune-related adverse events (irAEs) following pembrolizumab....
#1Pankaj JoshiH-Index: 9
#2Marco BandiniH-Index: 26
Last. Sanjay KulkarniH-Index: 10
view all 9 authors...
#1Giuseppe FallaraH-Index: 5
#2Marco BandiniH-Index: 26
Last. Zhe TianH-Index: 30
view all 18 authors...
#1Filippo PederzoliH-Index: 14
#2Irene LocatelliH-Index: 7
Last. Dejan LazarevicH-Index: 27
view all 17 authors...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.